// App-Quantinova.ai

: Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS).

Researchers

Presenter

  • Daniel W. Lin

Principal Investigators

  • Jesse McKenney

  • Marshall Brown

  • Ruixiao Lu

  • Michael Crager

  • Hilary Boyer

  • James D. Brooks

  • Atreya Dash

  • Michael Fabrizio

  • Martin Gleave

  • Michael A. Liss

  • Todd Matthew Morgan

  • Ian M Thompson

  • Andrew Wagner

  • Athanasios Tsiatis

  • Andrea Pingatore

  • H. Jeffrey Lawrence

  • Peter S Nelson

  • Lisa F Newcomb

Medical Centers

  • University of Washington, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Cleveland Clinic, Cleveland, OH

  • Genomic Health, Inc., Redwood City, CA

  • Genomic Health, Inc., Redwood City, CA

  • Department of Radiology, University of Washington, Seattle, WA

  • Eastern Virginia Medical School, Norfolk, VA

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • University of Michigan, Ann Arbor, MI

  • CHRISTUS Medical Center Hospital, San Antonio, TX

  • Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

  • Canada

Companies

  • Genomic Health, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Glasgow prognostic score

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved